Bladder Cancer Clinical Trial

A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy

Summary

The purpose of this study is to help us learn what is the best amount of fluid to give to patients during bladder surgery in order to avoid delayed bowel function after surgery, which could prolong hospital stay.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adults (21 years old or greater) who are able to provide informed consent
Patients who undergo an open, elective radical cystectomy

Exclusion Criteria:

Patients with active atrial fibrillation or flutter, since the algorithm is not accurate in case of cardiac arrhythmia
Female patients who are pregnant (female patients of child-bearing potential must have a negative serum pregnancy test ≤ 14 days prior to surgery or 15 to 30 days prior to surgery with a negative urine pregnancy test the morning of surgery)
Presence of ascites, because increased abdominal pressure interferes with EV1000 reading accuracy
BMI > 45 or <17, because increased abdominal pressure interferes with EV1000 reading accuracy

Study is for people with:

Bladder Cancer

Phase:

Phase 3

Estimated Enrollment:

282

Study ID:

NCT02145871

Recruitment Status:

Completed

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 5 Locations for this study

See Locations Near You

Memorial Sloan Kettering Basking Ridge
Basking Ridge New Jersey, 07920, United States
Memorial Sloan Kettering Monmouth
Middletown New Jersey, 07748, United States
Memorial Sloan Kettering Cancer Center @ Commack
Commack New York, 11725, United States
Memorial Sloan Kettering Westchester
Harrison New York, 10604, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10021, United States

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Phase:

Phase 3

Estimated Enrollment:

282

Study ID:

NCT02145871

Recruitment Status:

Completed

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.